_david-collier-clinical-director-william-harvey-clinical-research-centre-barts-amp-the-london-qmul-talks-pcsk9-amp-fourie.jpg "David Collier, Clinical Director, William Harvey Clinical Research Centre, Barts & The London QMUL talks PCSK9 & FOURIER study from pcsk Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 6 min 93 sec
✓ Published: 19-Mar-2017
✓ Published: 19-Mar-2017
Description:
David Collier outlines the importance of the FOURIER study in which patients at the William Harvey Clinical Research Centre have been involved. Some of their personal stories are also available on this site.nThis video was produced for the announcement of the results of the FOURIER study, funded by Amgen, in March 2017.nProduction for TrialsConnect was by Greenacre Communications – a London-based video production company specialising in health-care issues and started by John, a former patient
David Collier outlines the importance of the FOURIER study in which patients at the William Harvey Clinical Research Centre have been involved. Some of their personal stories are also available on this site.nThis video was produced for the announcement of the results of the FOURIER study, funded by Amgen, in March 2017.nProduction for TrialsConnect was by Greenacre Communications – a London-based video production company specialising in health-care issues and started by John, a former patient
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_pcsk9-inhibitors-single-agent-or-with-ezetimibe.webp "HCPLive")
_le-pcsk9-une-dcouverte-francophone-pr-catherine-boileau.webp "Le PCSK9, une découverte francophone. Pr Catherine Boileau from pcsk")
_pcsk9-inhibitors-explained-in-3-minutes.webp "Drug Matters")
_the-cholesterol-wars-identifying-patients-who-would-most-benefit-from-pcsk9-inhibitors-part-1.webp "NAThrombosisForum")
⏲ 58 minutes 8 seconds 👁 346
_oral-pcsk9-inhibitor-safety-and-efficacy-in-hypercholesterolemia-with-dr-ballantyne.webp "FITsOnTheGO")
⏲ 13 minutes 8 seconds 👁 839
_repatha-pcsk9-inhibitor-use-development-amp-very-low-ldl-levels.webp "Dr. Ford Brewer MD MPH - PrevMed Health")
_the-pcsk9-inhibitors.webp "The PCSK9 Inhibitors from pcsk")
_pcsk-feat-trill300.webp "Drøse183 - Topic")
_pcsk9-inhibitors-single-agent-or-with-ezetimibe.jpg)
_le-pcsk9-une-dcouverte-francophone-pr-catherine-boileau.jpg)
_pcsk9-inhibitors-explained-in-3-minutes.jpg)
_the-cholesterol-wars-identifying-patients-who-would-most-benefit-from-pcsk9-inhibitors-part-1.jpg)
_oral-pcsk9-inhibitor-safety-and-efficacy-in-hypercholesterolemia-with-dr-ballantyne.jpg)
_repatha-pcsk9-inhibitor-use-development-amp-very-low-ldl-levels.jpg)
_the-pcsk9-inhibitors.jpg)
_pcsk-feat-trill300.jpg)
![[+]](/images/menu.gif){kind=small}